Patents expiring in 2037

US 9637483

Heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9636408

Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

TONIX PHARMA LIMITED · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9636301

In vitro release assay for liposome encapsulated vincristine

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2017072335

UTILISATION DE MASITINIB ET D'AUTRES INHIBITEURS DE MASTOCYTE POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON

AB SCIENCE [FR] · Granted Thu May 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2017119760

USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

AB SCIENCE [FR] · Granted Thu May 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protein HLA class I restricted T-cell epitopes

United States of America as represented by the Secretary of the Air Force · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642916

Porphyrin modified telodendrimers

The Regents of the University of California · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9643961

Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activities

Almirall, S.A. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642898

Use of serine protease inhibitors in the treatment of neutropenia

MED DISCOVERY S.A. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644018

Antibody modulators of APLNR

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644238

Methods of isolating non-senescent cardiac stem cells and uses thereof

AUTOLOGOUS REGENERATION, LLC · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642391

Anti-regurgitation composition maintaining gut motility

UNITED PHARMACEUTICALS · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642805

Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy

Northwestern University · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642861

Methods of treating oral mucositis

Galera Labs, LLC · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9645139

Neuroprotective chemicals and methods for identifying and using same

The Board of Regents of the University of Texas System · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642909

Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants

Sanaria Inc. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644224

Methods for cyclizing synthetic polymers

Rigel Pharmaceuticals, Inc. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644216

Adeno-associated virus vectors for treatment of glycogen storage disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644179

Use of PDL1 expressing cells to convert T cells into regulatory T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644039

Acid-degradable and bioerodible modified polyhydroxylated materials

The Regents of the University of California · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644201

Structured peptide processing

BICYCLE THERAPEUTICS LIMITED · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644170

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644169

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644004

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9643967

Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644016

Soluble notch receptor proproteins and methods of use thereof

CytomX Therapeutics, Inc. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9644207

Compositions and methods for modulating Tau expression

Ionis Pharmaceuticals, Inc. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9643957

Heterocyclic compounds having cholesterol 24-hydroxylase activity

Takeda Pharmaceutical Company Limited · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642946

Medical device with intrapore films

Covidien LP · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642894

Compositions for rapidly treating severe hypoglycemia

XERIS PHARMACEUTICALS, INC. · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642859

Use of capsazepine and analogs thereof to treat cancer

The Board of Regents of the University of Texas System · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9642843

Pharmaceutical compounds and use of same in cancer and tauopathies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9649320

Non-hormonal steroid modulators of NF-κB for treatment of disease

ReveraGen BioPharma, Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9649291

Treatment for obesity

Jazz Pharmaceuticals International III Limited · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9649343

Compositions and methods for transplantation of colon microbiota

National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9649364

Methods for producing stable therapeutic formulations in aprotic polar solvents

XERIS PHARMACEUTICALS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650256

Cerium oxide-aluminosilicate tubes nanocomposite and method of preparation

TOVARISTVO Z OBMEZHENOU VIDPOVIDALNISTU “NANOMEDTRAST” · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9651562

Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

The Regents of the University of California · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650381

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650421

Self-assembled nanostructures

Northwestern University · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650391

N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650636

Methods for treating hypercholesterolemia

Ionis Pharmaceuticals, Inc. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650417

Treatments for gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650395

Antibacterial compounds and methods for use

PTC THERAPEUTICS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650436

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650607

Modalities for the treatment of degenerative diseases of the retina

Astellas Institute for Regenerative Medicine · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650447

Complement receptor 2 (CR2) targeting groups

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9650444

Anti-PDGFR-beta antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)